drospirenone: Clinical Trials

8 trials of drospirenone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 active not recruiting, 1 not yet recruiting, 1 withdrawn. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Completed 5, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1

Follow drospirenone: new trials by email Literature Review of drospirenone trials Research Report on drospirenone

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Randomized Feasibility Trial Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in Preeclampsia
Norethindrone 0.35 MG, Drospirenone - Hypertension, Preeclampsia
Phase 4Not yet recruitingOregon Health and Science University502026-07-012025-12-19
The Use of Drospirenone/Estetrol in Random Start Rapid Endometrial Preparation
drospirenone/estetrol 3mg/14.2mg - Endometrial Polyp, Endometrial Diseases
Phase 4CompletedUniversity of Palermo802023-01-012024-04-08
LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women
drospirenone 4 mg oral tablet or drospirenone 3.5 mg chewable tablet - Change in Bone Mineral Density, Bone Loss
Phase 4Active not recruitingInsud Pharma15362022-03-282026-04-09
Treatment Choice in Primary Dysmenorrhea
estradiol valerate/dienogest, ethinylestradiol and drospirenone - Primary Dysmenorrhea
Phase 4CompletedAdana Numune Training and Research Hospital992015-01-152017-04-26
The Effect of Oral Contraceptives on Women Balance
COC containing 30 μg of EE and 3mg of drospirenone - Joint Stabilioty
Phase 4CompletedCairo University1002015-01-012016-08-04
Comparison of Levonorgestrel Intrauterine System, Copper T Intrauterine Device and Oral Contraceptives on Life Quality
YASMIN® (Drospirenone/Ethinyl Estradiol), The Copper-T is an intrauterine device (IUD), levonorgestrel-releasing system - Contraceptive Methods Comparison
Phase 4WithdrawnIstanbul Training and Research Hospital2012-12-012020-08-13
Premenstrual Symptoms Treatment Comparing Between Oral Contraceptives Containing Desogestrel and Drospirenone
EE 20 microgram with desogestrel 150 mg, EE 20 microgram with drospirenone 3 mg - Premenstrual Syndrome
Phase 4CompletedChulalongkorn University902011-06-012012-03-14
Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women
Yasmin (DRSP 3mg/EE 0.03 mg), Microgynon (LNG 0.15 mg/EE 0.03 mg) - Healthy
Phase 4CompletedBayer432003-06-012014-12-30

Conditions studied

Bone Diseases, Metabolic (1)  ·  Hypertension (1)  ·  Osteoporosis (1)  ·  Pelvic Pain (1)  ·  Pre-Eclampsia (1)  ·  Premenstrual Syndrome (1)  ·  Thrombosis (1)  ·  Uterine Diseases (1)

Sponsors

Adana Numune Training and Research Hospital (1)  ·  Bayer (1)  ·  Cairo University (1)  ·  Chulalongkorn University (1)  ·  Insud Pharma (1)  ·  Istanbul Training and Research Hospital (1)  ·  Oregon Health and Science University (1)  ·  University of Palermo (1)

Countries

United States (2)  ·  Czechia (1)  ·  Egypt (1)  ·  Germany (1)  ·  Italy (1)  ·  Poland (1)  ·  Thailand (1)  ·  Turkey (Türkiye) (1)

Top investigators

Ahmed Maged, MD (1)  ·  Enrico Colli, MD (1)  ·  Gulsum Uysal, M.D (1)  ·  Jirath Wichianpitaya, M.D. (1)  ·  Julia Tasset (1)  ·  Surasak Taneepanichskul, M.D. (1)

Results publications

PMID 28805601